Patterned surfaces that present specific ligands in spatially defined arrays are used to examine structural linkages between clustered IgE receptors (IgE-FcRI) and the cytoskeleton in rat basophilic leukemia (RBL) mast cells. We showed with fluorescence microscopy that cytoskeletal F-actin concentrates in the same regions as cell surface IgE-FcRI that bind to the micrometer-size patterned ligands. However, the proteins mediating these cytoskeletal connections and their functional relevance were not known. We now show that whereas the adaptor proteins ezrin and moesin do not detectably concentrate with the array of clustered IgE-FcRI, focal adhesion proteins vinculin, paxillin, and talin, which are known to link F-actin with integrins, accumulate in these regions on the same time scale as F-actin. Moreover, colocalization of these focal adhesion proteins with clustered IgE-FcRI is enhanced after addition of fibronectin-RGD peptides. Significantly, the most prominent rat basophilic leukemia cell integrin (␣5) avoids the patterned regions occupied by the ligands and associates preferentially with exposed regions of the silicon substrate. Thus, spatial separation provided by the patterned surface reveals that particular focal adhesion proteins, which connect to the actin cytoskeleton, associate with ligand-cross-linked IgE-FcRI, independently of integrins. We investigated the functional role of one of these proteins, paxillin, in IgE-FcRI-mediated signaling by using small interfering RNA. From these results, we determine that paxillin reduces stimulated phosphorylation of the FcRI ␤ subunit but enhances stimulated Ca 2؉ release from intracellular stores. The results suggest that paxillin associated with clustered IgE-FcRI has a net positive effect on FcRI signaling.
C
ells have evolved to respond to their chemical and physical environment. Chemical stimulants in the form of soluble or surface-bound ligands are recognized by specific cell surface receptors, and physical cues are sensed by integrins that bind to extracellular matrix proteins on surrounding substrates (1) . Cross-talk between intracellular signaling pathways that are initiated by integrins and by ligand receptors has been clearly demonstrated, although spatial aspects of these processes have not been defined. Surfaces patterned on the micrometer scale offer the opportunity to separate regions that bind integrins from those that present ligands to cell surface receptors and thereby delineate respective cytoskeletal connections.
The subject of our study is the IgE receptor (FcRI), which is a member of the family of multisubunit immune recognition receptors that includes antigen receptors on B cells and T cells. This family of receptors has conserved structural features and similarly initiates intracellular signaling in response to multivalent ligands (antigens) that activate cells by clustering cell surface receptors. FcRI receptors are found primarily in mast cells and basophils and are sensitized to a particular antigen by high-affinity binding of IgE with the corresponding specificity. Cross-linking of IgE-FcRI by antigen triggers intracellular signaling events, leading to multiple cellular responses, including degranulation to release chemical mediators that cause inflammatory and allergic reactions. In the earliest signaling events, antigen-induced clustering of IgE-FcRI causes stable association with ordered lipid domains, wherein the tyrosine kinase Lyn phosphorylates the FcRI ␤ and ␥ subunits, resulting in recruitment and activation of tyrosine kinase Syk (2, 3) . Activated Syk phosphorylates a series of proteins resulting in Ca 2ϩ mobilization and other downstream signaling steps leading to degranulation.
We recently examined spatial relationships during IgE-FcRImediated signal transduction by using microfabricated ligand arrays. The patterned ligands cause spatially defined clustering of IgE-FcRI on the cell surface which, because the IgE binds to the ligands, corresponds to the same pattern. These patterned ligands and binding receptors can be visualized with fluorescence microscopy; the periodicity of the patterns enables reliable and quantitative evaluation of localized receptors and signaling components that coredistribute.
We showed with patterned lipid bilayers containing 2,4-dinitrophenyl (DNP) ligands that tyrosine kinase activity (as visualized with anti-phosphotyrosine antibodies) occurs in the liganded regions on the same time scale that anti-DNP IgEFcRI clusters in those regions, and detectable accumulation of the Lyn-GFP kinase occurs after Ϸ15 min. Cytoskeletal F-actin visually concentrates in these regions after Ϸ30 min. Notably, cytochalasin D, which inhibits actin polymerization, prevents the micrometer-scale accumulation of Lyn but not the initial tyrosine phosphorylation (4), supporting the view that the actin cytoskeleton becomes involved as signaling progresses.
The present work examines the reorganization and the regulatory role of the actin cytoskeleton during FcRI-mediated signal transduction, and we focus on participation of several actin-binding proteins that have been examined in other signaling pathways. In particular, we investigate ezrin and moesin, which have been implicated in T cell receptor signaling, and paxillin, vinculin, and talin, which are known to be involved in focal adhesion complexes and participate in integrin-mediated signaling (5) . The adaptor protein paxillin has several binding sites for Src kinases that are relevant in immune cell signaling (6) . Previous studies on rat basophilic leukemia (RBL) mast cells showed that paxillin is tyrosine-phosphorylated after activation of IgE-FcRI by multivalent ligand (7) . Another study identified paxillin as a protein precipitated by a maltose binding proteinLyn fusion protein only after ligand-mediated clustering of IgE-FcRI in RBL mast cells, suggesting that this protein is involved in signaling events downstream of the initial phosphorylation of FcRI (8) . Our present work with patterned ligands shows that focal adhesion proteins vinculin, talin, and paxillin coredistribute with clustered IgE-FcRI independently from integrins and thereby provide a direct link to the actin cytoskeleton. Moreover, use of short interfering RNA (siRNA) to knock down paxillin expression shows that paxillin plays a regulatory role in IgE-FcRI signaling. Thus, micropatterned ligand arrays, together with biological manipulation of cellular components, reveals spatially distinctive control of cell signaling by receptors and integrins.
Results

F-actin in RBL Cells Redistributes Reversibly with IgE-FcRI That Are
Clustered by Micropatterned Ligands. We labeled F-actin with Alexa Fluor 568 phalloidin at various time points after incubating anti-DNP IgE-sensitized RBL cells with the substrates at 37°C. Consistent with our previous results obtained with actin-EGFP (4), we observed accumulation of the actin label over the patterned features after 25-min stimulation (Fig. 1A) , and the percentage of cells showing clear actin patches became maximal (typically 70% of the cells) after Ϸ40 min. These patches are observed on top of a diffuse background of cortical actin stain, and some day-to-day variability of detected colocalization with the patterned bilayers is caused by this background fluorescence. We investigated the specificity and stability of visibly coclustered IgE- S1 ]. These results demonstrate that cytoskeletal actin coredistribution occurs specifically with clustered IgE-FcRI and is reversible, pointing to the presence of connecting proteins that sense the state of IgE-FcRI aggregation.
Pretreatment of cells with inhibitors of actin polymerization such as cytochalasin D prevents coredistribution of F-actin with IgE-FcRI that is clustered by patterned ligands, as shown in ref. 4 . In contrast, we find that colocalized IgE-FcRI and F-actin patches, as reported by actin-EGFP on live cells, are not reversed if cytochalasin D (4 M) is added after these patches are formed (Fig. S1 ). These results indicate the polymerized actin associated with the clustered receptors forms stable structures, probably by means of proteins that cross-link F-actin.
We evaluated members of the ezrin/radixin/moesin (ERM) family that are involved in coupling some signaling components in the plasma membrane with the actin cytoskeleton (9) . In particular, ERM adaptors have been implicated in regulation of the immunological synapse in T cells (10) . Antibodies specific for either ezrin or moesin were added to cells that had been fixed after incubation with the patterned ligands for periods up to 1 h, followed by fluorescent secondary antibody. Although a diffuse membrane stain could be seen, no concentration of anti-ezrin or anti-moesin with the pattern of clustered IgE-FcRI was detected in numerous experiments of this type ( Fig. 1 A) .
Focal Adhesion Proteins Coredistribute with Clustered IgE-FcRI.
Vinculin, talin, and paxillin are involved in complexes associated with focal adhesions that form when integrins bind to extracellular matrix (ECM) proteins, such as fibronectin, and consequently form linkages to the cytoskeleton (5). With antibodies specific for vinculin and talin we observed recruitment of both of these proteins to the patches of IgE-FcRI that form in RBL cells after incubation with the patterned, liganded substrates. The kinetics of this accumulation is very similar to that of F-actin: resolvable patches of vinculin or talin appear after Ϸ25 min and become maximal after Ϸ40 min (Fig. 1B) . The number of cells with detectable patches of talin, typically 25%, is less than that for vinculin, typically 70%, and this finding may be caused by differences in antibodies or different levels of specific background staining that affects contrast. The stain that concentrates with the patches sometimes appears ring-like, suggesting limited accessibility.
RBL cells adhere to and spread on glass possibly by means of fibronectin or other ECM proteins secreted by these cells, and attached cells labeled with anti-vinculin exhibit structures resembling focal adhesions (see Fig. S4 ). On substrates patterned with lipid bilayers, the cells adhere in regions between the patterned features. To test dependence of IgE-FcRI, vinculin, and talin clustering on integrin engagement and activation, we used soluble RGD peptides that compete with fibronectinbinding sites. We found that addition of 0.5-1 mg/ml GRGDSP or GRGDPT peptides, known to inhibit integrin-mediated cellular attachment (11) , causes reduced cell spreading on the substrate, but this treatment does not prevent patches of vinculin and talin in regions of the pattern ligands (Fig. 1B) . On the contrary, we find that this treatment increases the accumulation of these focal adhesion proteins in these regions, probably because they have been released from integrin complexes.
Control experiments and quantitative analyses were carried out. Direct comparison of patterned lipid bilayers containing or not containing the DNP-cap-PE ligand showed that vinculin and talin coredistribute with IgE-FcRI only when the specific ligand is present (Fig. S2) . In other experiments, patterned lipid bilayers were replaced by patterned BSA conjugated to DNP (DNP- BSA) by using the same lithographic mask and Parylene liftoff method. These substrates were tested with RBL cells sensitized or not with anti-DNP IgE, and vinculin, paxillin, ezrin, or moesin was fluorescently labeled. None of these markers clustered with the patterned DNP-ligand for cells without IgE bound to FcRI, whereas vinculin and paxillin but not ezrin or moesin formed patterned clusters on cells with bound IgE. Cross-correlation analysis provides quantitative confirmation of these results (Fig. S3) We investigated whether the association of actin and focal adhesion protein vinculin with clustered IgE-FcRI is affected by early signaling activities stimulated by these receptors. We treated cells with two different inhibitors of Syk kinase that is activated by clustered IgE-FcRI after receptor phosphorylation by Lyn kinase (12) . Addition of Syk inhibitor SI (1 M) (13) or piceatannol (40 M) before and during incubation of cells with liganded substrates had no detectable effect on redistribution of vinculin or actin with the clustered receptors. The same concentrations of these Syk inhibitors reduce antigen-stimulated degranulation by 75-80%. We also tested PP1 (15 M), which inhibits Lyn and other Src family kinases, and this inhibitor reduced by half the percentage of cells showing coredistribution of actin or vinculin with clustered receptors. Cytochalasin D (2 M) completely abrogates F-actin recruitment, as described above, and this treatment similarly prevents patching of vinculin with clustered receptors. Our results with these inhibitors indicate that vinculin and actin redistribution with clustered IgEFcRI depends in part on Src family kinase activity but not on Syk activity.
We considered whether the accumulation of these focal adhesion proteins depends on mechanical tension induced by nonmuscle myosin II, a motor protein involved in regulation and distribution of actin filaments such as occurs during formation of stress fibers. As a test, we treated cells with blebbistatin, an inhibitor of myosin II ATPase activity, at a concentration of 50 M before and during 40-min incubation of cells with patterned DNP-ligands. This treatment decreased filamentous heterogeneity of fluorescently labeled vinculin or paxillin and enhanced rather than reduced coredistribution of actin (data not shown), vinculin, or paxillin with clustered IgE-FcRI compared with samples without blebbistatin (Fig. S3 A, B, and D) .
Paxillin Coredistributes with Clustered IgE-FcRI Independently of
Integrins. Paxillin is known to connect vinculin with other binding partners in focal adhesion complexes (Fig. S4) . We transfected RBL cells with the gene construct for paxillin-EGFP and observed coredistribution of the expressed protein with clustered IgE-FcRI after cells were incubated with patterned substrates (Fig. 2) . Clear patches of paxillin-EGFP emerged above the background level in many cells, typically in Ϸ35% after 40 min. In other experiments when anti-paxillin was used as the label, typically 70% of the cells showed coclustering with IgEFcRI (Fig. S3) .
As described in a previous section, we observed that soluble RGD peptides enhanced accumulation of vinculin and talin with clustered IgE-FcRI (Fig. 1B) . To investigate further whether these interactions of focal adhesion proteins are independent of integrin engagement and signaling, we evaluated RBL cells expressing a GFP construct of ␣5-integrin and compared these in the same experiment with cells expressing paxillin-EGFP. In contrast to paxillin, ␣5-integrin resists association with the lipid bilayer regions that contain the specific ligand DNP-cap-PE. This difference is striking in the images and can be quantified with line scans (Fig. 2) . Tested in several independent experiments, as many as 65% of cells expressing the EGFP-labeled integrin showed this exclusion, and concentration of this protein was never observed in the patterns. None of the other samples containing IgE-sensitized cells with labeled vinculin, talin, or paxillin ever showed this exclusion in many different experiments with the liganded arrays of lipid bilayers. This aversion of ␣5-integrin to the patterned regions is not caused by clustering and activation of the IgE receptors because the same occurs when the ligand, DNP-cap-PE, is not included in the lipid bilayers (data not shown).
Functional Role of Paxillin in IgE-FcRI Signaling. Our observation of paxillin clustering with IgE-FcRI on patterned bilayers, together with previous evidence that paxillin is involved in FcRImediated signaling (see Introduction), prompted us to examine more directly the functional importance of this adaptor protein.
For this purpose, we used siRNA to knock down expression of endogenous paxillin. Two different siRNA constructs caused Ͼ90% reduction of paxillin (Fig. 3A) . To evaluate participation of paxillin in coredistribution of F-actin with clustered IgE- FcRI, we stained knockdown and control cells with Alexa Fluor 568 phalloidin after a 40-min incubation with the patterned ligands. We detected no differences, indicating that although paxillin may be involved in linking clustered receptors to the cytoskeleton, it is not essential.
Measurements of receptor-mediated cellular responses were carried out on suspended cells to eliminate signaling effects caused by integrin-mediated binding to substrates. We evaluated effects of paxillin knockdown on tyrosine phosphorylation stimulated by IgE-FcRI by incubating suspended cells with multivalent ligand (DNP-BSA) and immunoblotting cell lysates with an anti-phosphotyrosine antibody. Paxillin knockdown cells yielded a pattern of stimulated tyrosine phosphorylation that was qualitatively similar to control cells treated with nonspecific siRNA (Fig. 3B) . However, the knockdown cells showed a clear and consistent increase in phosphorylation of two bands corresponding to molecular masses of 35 kDa (p35) and 50 kDa (p50) (Fig. 3 B-D) . The p35 band corresponds to FcRI ␤, as demonstrated (14); consistent with this assignment the phosphorylation of this band is maximal 3 min after the cells are stimulated with multivalent ligand at 37°C. In contrast, tyrosine phosphorylation of the p50 band is maximal 15 min after stimulation. The time course of phosphorylation of p50 is consistent with it being a substrate of Csk kinase that negatively regulates Src kinases (15) . These results with the knockdown cells suggest that paxillin, possibly by binding to Lyn, plays a negative regulatory role in Lyn phosphorylation of the p35 and p50 substrates.
We also evaluated downstream steps of activation in the paxillin knockdown cells. Stimulated Ca 2ϩ mobilization, which follows after initial FcRI phosphorylation and precedes cellular degranulation, occurs in two phases: release from intracellular stores and influx from extracellular medium. In buffer containing Ca 2ϩ , the paxillin knockdown cells show a small but consistent decrease in the Ca 2ϩ response (Fig. 4A) . To evaluate separately the stimulated Ca 2ϩ release from stores and Ca 2ϩ influx, antigen was added in buffer containing no Ca 2ϩ , and then Ca 2ϩ was added subsequently. Paxillin knockdown cells showed a consistent decrease of Ϸ50% in stimulated Ca 2ϩ release from the intracellular stores and a decrease of Ϸ10% in the Ca 2ϩ influx (Fig. 4 B and C) . These results are consistent with a negative regulatory effect of paxillin on Lyn-mediated activation of Csk or another negative regulator, which would result in an enhancing effect on antigen-stimulated Ca 2ϩ release from stores.
Discussion
The patterned lipid bilayer substrate we used in this work restricts integrin-mediated adhesion to nonliganded regions, and this spatial separation reveals that actin-binding proteins vinculin, talin, and paxillin interact with ligand-clustered IgE-FcRI in mast cells, independently of integrins. Our results suggest that these characteristic focal adhesion proteins serve to connect clustered IgEFcRI to cytoskeletal actin, which also coredistributes with these receptors and may regulate receptor-mediated signaling. We and others demonstrated the versatility of patterned ligands that confine and activate receptors in micrometer-size regions so that the spatially regulated cellular responses can be monitored (for review, see ref. 16 ). An important feature of patterned lipid bilayers is that proteins do not adhere nonspecifically to the lipid regions: anti-DNP IgE-FcRI binds selectively to these regions only because DNP-cap-PE is incorporated in the bilayers (17) . In contrast, the most prominent RBL cell integrin (␣5) avoids the regions of the lipid bilayers and binds to the glass surface by means of ECM proteins secreted by the cells. Others also showed that supported lipid bilayers are resistive to protein absorption and cell adhesion (18) . Our experiments indicating that characteristic focal adhesion proteins connect antigen-clustered IgE-FcRI to the cytoskeleton provide insight to increasing evidence for cytoskeletal regulation of FcRI signaling (19) (20) (21) (22) (23) . We showed that F-actin coconcentrates with IgE-FcRI that is clustered in patches by immobilized DNP-ligands. This coredistribution is prevented, but not reversed, by cytochalasin D, suggesting stabilization of the polymerized F-actin by actin-binding proteins. In contrast, both IgE-FcRI clustering and coconcentrating F-actin are reversed by soluble multivalent ligand that competes with the immobilized DNP-ligand. This dynamic, reversible process indicates that the linkage to the cytoskeleton is based on complexes forming stably with FcRI only after oligomerization by multivalent ligand binding.
To investigate the composition of complexes that connect to the cytoskeleton, we examined several known actin-binding proteins. We detected no coredistribution of ezrin and moesin when sensitized cells are incubated with patterned ligands, in contrast to clear coredistribution of vinculin, talin, and paxillin. Moreover, these latter proteins accumulate visibly in the same patterns as the clustered IgE-FcRI with kinetics similar to that observed for F-actin. Interactions among paxillin, vinculin, talin, and actin have been established in the context of integrin-based focal adhesion complexes (5, 24) : Vinculin binds directly to paxillin and actin, whereas talin binds actin and vinculin as a result of integrin engagement. The patterned substrates revealed that complexes containing these components form in regions of clustered IgE-FcRI, even when integrins (as represented by ␣5) are excluded from these regions.
Our finding that Syk inhibitors, SI and piceatannol, do not inhibit vinculin and actin accumulation whereas the Src family tyrosine kinase, PP1, partially inhibits both suggests that the linkage between FcRI and the cytoskeleton is enhanced by stimulated Lyn kinase activity and occurs before activation of Syk substrates or in parallel signaling pathways. Paxillin is tyrosine-phosphorylated after antigen activation in RBL mast cells (7) and has been found to interact with Lyn kinase in this and several other cell types (8, 25, 26) , suggesting that paxillin is one of the proteins that provides a link to vinculin, talin, and thereby to the actin cytoskeleton.
The observed interactions of focal adhesion proteins with clustered IgE-FcRI also lend insight to apparent signaling cross-talk between these receptors and integrins. For example, it is known that adherence of RBL-2H3 cells to fibronectin-coated surfaces enhances degranulation and serves as a costimulus for cytokine production (27) (28) (29) . Similarly, cell activation by antigen-mediated clustering of IgE-FcRI causes increased adhesion and spreading in mast cells (30, 31) . We demonstrated competing binding sites for focal adhesion proteins: soluble RGD peptides compete with immobilized fibronectin and bind integrins, consequently releasing vinculin and talin to increase their concentration with the clustered IgE-FcRI.
The spatially distinctive information provided by the micropatterned ligand arrays is complemented with cell biological experiments. We found that substantially reducing paxillin in RBL cells with siRNA clearly enhances tyrosine phosphorylation of two proteins in response to stimulation by multivalent ligand: The p35 band we can identify as FcRI ␤ subunit, and the unidentified p50 band. Enhanced phosphorylation of FcRI ␤ stimulated by antigen was also seen for RBL cells treated with inhibitors of actin polymerization, cytochalasin D, and latrunculin (19, 20, 22) . These results are consistent with the view that negative regulation of Lyn kinase mediated by paxillin (possibly by linking to the cytoskeleton) occurs during early stages of IgE-FcRI signaling, when Lyn phosphorylates FcRI ␤ and ␥ subunits after antigen-mediated clustering of these receptors (32) . This inhibitory effect of paxillin is also evident at later stages because of altered phosphorylation of the p50 protein, which may be a substrate of CSK or another negative regulatory kinase. Suppression by paxillin results in enhanced downstream signaling, as manifested by enhanced Ca 2ϩ mobilization. Paxillin knockdown cells showed only a small inhibitory effect on stimulated degranulation (Fig. S5) , which is one end point of the cellular response. This result is not surprising because of the relatively modest inhibition of total Ca 2ϩ mobilization. It is possible that other proteins compensate for paxillin knockdown or that paxillin plays a larger regulatory role in other stimulated cellular responses, such as cytokine production. In this regard, leupaxin (a member of the paxillin family of adaptor proteins) recently was shown to regulate cytokine production resulting from B cell receptor signaling (26) . Paxillin knockdown in RBL cells did not detectably affect F-actin coredistribution with clustered IgE-FcRI on patterned bilayers, indicating that other proteins are also involved in these linkages, and these may have other regulatory effects. As demonstrated in this work, candidate proteins can now be examined with patterned substrates, pharmacological and genetic manipulation, and biological measurements.
Experimental Procedures
Materials. 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), DNPcap-PE, and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (lissamine rhodamine PE) were purchased from Avanti Polar Lipids. Mouse monoclonal anti-DNP IgE was purified as described in ref. 33 and fluorescently modified with Alexa Fluor 488 (Molecular Probes) according to the labeling kit instructions. Cytochalasin D, mouse anti-vinculin (clone hVIN-1), and mouse anti-talin (clone 8d4) antibodies were purchased from Sigma-Aldrich. Alexa Fluor 568 phalloidin was purchased from Molecular Probes. Syk kinase inhibitor 3-(1-methyl-1H-indol-3-yl-methylene)-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide (SI), trans-3,3Ј,4,5Ј-tetrahydroxystilbene (piceatannol), (Ϫ)-blebbistatin, and RGD peptides, GRGDSP, and GRGDPT were purchased from Calbiochem. Monoclonal anti-phosphotyrosine clone 4G10 was obtained from Upstate Cell Signaling Solutions (Millipore), monoclonal anti-␣-tubulin (clone .N.593) from U.S. Biologicals, and monoclonal anti-paxillin clone 349 from BD Biosciences. Rabbit anti-ezrin and anti-moesin antibodies were gifts from A. Bretscher (Cornell University, Ithaca, NY). Integrin ␣5-EGFP and avian paxillin-EGFP cDNA constructs were gifts from A. Horwitz (University of Virginia, Charlottesville, VA). Actin-EGFP was a gift from A. Jeromin (Allen Institute, Seattle, WA).
Microfabrication of Patterned Ligands by Polymer Liftoff.
Surfaces were patterned with 1-to 5-m features as described (4, 17) , and no significant differences were observed over this length range. Most experiments used patterned lipid bilayers containing POPC, DNP-cap-PE (and sometimes lissamine rhodamine PE) and omitted the DNP-ligand as a specificity control (7, 8) . For further evaluation, additional experiments used patterned BSA that was conjugated with DNP and a fluorescent marker. Additional details are provided in SI Methods.
Cell Culture and Transfection. RBL-2H3 cells were maintained in monolayer cultures and harvested with trypsin-EDTA (Invitrogen) 3-5 days after passage, as described in ref. 34 . Cells were sensitized by overnight incubation at 37°C with Alexa Fluor 488-labeled IgE or unlabeled IgE (0.5 g/ml). For some experiments, cells were transiently transfected with specified EGFP constructs by using Lipofectamine 2000 (Invitrogen). Cells were suspended in buffered saline solution [135 mM NaCl, 5.0 mM KCl, 1.8 mM CaCl 2, 1.0 mM MgCl2, 5.6 mM glucose, 20 mM Hepes (pH 7.4)] containing 1 mg/ml BSA. In some experiments, cells were incubated with specific inhibitors or other agents at 37°C for 5 min before and during the time of incubation with the patterned substrates.
Fluorescence Microscopy and Immunofluorescence. Cells suspended at a concentration of 10 6 cells per ml were added to a patterned substrate (8 ϫ 8 mm) in the center of a 35-mm Petri dish with coverglass bottom (0.16 -0.19 mm; MatTek). After the specified incubation at 37°C (20 -45 min), cells were imaged directly (live-cell imaging), or they were fixed with 3.7% formaldehyde in PBS for 10 min followed by quenching with 10 mg/ml BSA in PBS. For immunofluorescence after fixation, cells were labeled with primary antibody at room temperature for 1 h. After washing with PBS/BSA (1 mg/ml), the Alexa Fluor 568-labeled secondary antibody was incubated with samples at room temperature for 1 h. Control samples, which had nonspecific mouse IgG as the primary antibody, were evaluated to confirm negligible nonspecific label and bleedthrough from the other fluorescence channel. Six to 12 independent experiments were carried out for each fluorescently labeled cellular component (e.g., ezrin, moesin, vinculin, and others).
A Bio-Rad-MRC600-confocal head coupled with a Zeiss Axiovert 10 inverted microscope was used for confocal microscopy. A 522/DF35 filter set was used for simultaneous or sequential dual-color image acquisition with an oilimmersion ϫ63, 1.4 numerical aperture objective. Two milliliters of buffered saline solution/BSA (for live cell imaging) or PBS (for fixed cells) was added into the dish before inverting the chip for microscopy observation. Positive cells showed fluorescent patterns that matched the substrate with intensity in the overlapping patches at least three times greater than the background level. Visual and quantitative analysis of the images is detailed in SI Methods.
Knockdown of Paxillin with siRNA. Predesigned On-TARGETplus SMARTpool siRNA (siRNA 1) targeting rat paxillin (Dharmacon) was used to reduce paxillin expression levels in RBL-2H3 cells. The siRNA pool sense sequences were GGAACUUCUUCGAGCGGGAUU, CCAGAAGGGUUCCACGAGAUU, GGCA-AAGCCUACUGUCGGAUU, and GCGAGGAGGAACACGUCUAUU. An additional predesigned siRNA (Ambion) with the sequence GCUCCAGCAC-CAAAAAUUC (siRNA 2) was used to confirm the results from the functional assays. A siRNA (On-TARGETplus siCONTROL; Dharmacon) with the sequence UGGUUUACAUGUCGACUAA was used as the nonspecific (sham knockdown) control. For optimal delivery of siRNA, cells were resuspended in buffer [137 mM NaCl, 2.7 mM KCl, 1 MgCl2, 5.6 mM glucose, 20 mM Hepes (pH 7.4)] at a concentration of 1 ϫ 10 7 cells per ml and, after addition of 1.5 nM siRNA, electroporated by using an exponential pulse at 280 V and 950 F. Electroporation was carried out in a 4-mm cuvette by using a Gene Pulser Xcell electroporator system (Bio-Rad). After electroporation, cells were plated in medium at a 25-30% confluence and incubated at 37°C for 48 h. Protein knockdown was confirmed by immunoblotting.
Cell Lysis and Immunoblotting. Whole-cell lysates were prepared on ice by suspending cells in lysis buffer [5 mM N-ethylmaleimide, 1 mM Na3VO4, 5 mM Na2P2O7, 50 mM NaF, 2 mM iodoacetate, 5 mM EDTA, 0.1% (vol/vol) Triton X-100, 50 mM NaCl, 50 mM Tris and 2% protease inhibitor mixture (Sigma), pH 7.6]. Lysates were centrifuged at 15,000 ϫ g for 10 min at 4°C. The supernatant was mixed with Tris-glycine SDS buffer and boiled for 5 min. Samples were resolved on a 12% Tris-glycine polyacrylamide gel and transferred to an Immobilon-P membrane with a pore size of 0.45 m (Millipore) by semidry transfer. Immunoblots were visualized with the Enhanced Chemiluminescence method by using the appropriate antibodies.
Antigen-Stimulated Degranulation. RBL cells (1 ϫ 10 6 cells per well in a 96-well plate, or 2 ϫ 10 6 cells per ml in suspension) were sensitized with anti-DNP IgE as described above. Multivalent ligand DNP-BSA (final concentration 100 ng/ml) was added as the stimulus, and cellular degranulation was quantified with a ␤-hexosaminidase colorimetric assay (35) . Degranulation was expressed as a percentage of the total ␤-hexosaminidase released from cells after lysis with 0.1% Triton X-100.
Measurement of Intracellular Ca 2؉ Mobilization. Cells were loaded with Indo-1 AM (Molecular Probes), and fluorescence was measured on an SML 8100S fluorometer in a time-based acquisition mode as described in ref. 23 . The maximum fluorescence from each sample was measured after lysing cells with 0.1% Triton X-100. Background fluorescence was measured by adding EDTA to the buffer. The Ca 2ϩ response was quantified by using a normalization factor for each condition as described in ref. 23 .
